You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Musculoskeletal conditions
  5. Arthritis

Golimumab for the treatment of psoriatic arthritis

  • Technology appraisal guidance
  • Reference number: TA220
  • Published:  27 April 2011
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

TA220 Psoriatic arthritis - golimumab: Appendix B - proposal paper presented to the Institute's Guidance Executive

TA220 Psoriatic arthritis - golimumab: Appendix B - proposal paper presented to the Institute's Guidance Executive TA220 Psoriatic arthritis - golimumab: Appendix B - proposal paper presented to the Institute's Guidance Executive
17 June 2013
(443.99 Kb 9 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 17 June 2013

Back to top